Rani Therapeutics Holdings, Inc. (RANI) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-05

Rani Therapeutics Holdings, Inc. (RANI) has filed 9 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-05. 4 Form 8-K material event filings were reported by RANI in the last 90 days. InsiderAlpha tracks every RANI SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Rani Therapeutics Holdings, Inc. (RANI)

SEC CIK	0001856725

90-Day SEC Filing Activity

Form 4 filings (90d)	9
Form 8-K filings (90d)	4
Latest Form 4 filing	2026-06-05

Recent RANI Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2024-12-13	McKinley Kate	Chief Business Officer	P — Open-market purchase	18.0K	$1.67	$30K	SEC
2024-12-09	Imran Talat	Chief Executive Officer	P — Open-market purchase	10.3K	$1.94	$20K	SEC
2024-10-15	South Cone Investments Limited Partnership	10% Owner	S — Open-market sale	3.31M	$2.55	$8.44M	SEC
2024-10-15	South Cone Investments Limited Partnership	10% Owner	S — Open-market sale	523.7K	$3.26	$1.71M	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Rani Therapeutics Holdings, Inc. (RANI). Updated in real time as new filings are submitted to the SEC.

Most-Active RANI Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Ausiello Dennis A	1	—
McKinley Kate	1	—
Bassan Abraham	1	—
IMRAN MIR A	1	—
BUTEL JEAN LUC	1	—

Recent RANI Form 8-K Material Events

2026-06-29 — Item 5.02, 9.01 [SEC]
2026-05-28 — Item 5.07 [SEC]
2026-05-27 — Item 8.01, 9.01 [SEC]
2026-05-15 — Item 2.02, 3.01, 5.02, 9.01 [SEC]
2026-03-26 — Item 2.02, 9.01 · Earnings · neutral [SEC]
Rani Therapeutics issued a press release on March 26, 2026 providing a corporate update and announcing financial results for Q4 and full year 2025. The filing contains standard financial reporting without explicit beat/miss or guidance language.

Recent Insider Filings

2026-06-05 — McKinley Kate (Chief Business Officer)
2026-06-05 — Javadi Alireza (Chief Technical Officer)
2026-06-05 — Imran Talat (Chief Executive Officer)
2026-06-01 — Bassan Abraham (Insider)
2026-06-01 — Rometty Lisa Ann (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in RANI insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

RANI Insider Trading — FAQ

What is the latest insider trade for RANI?: Rani Therapeutics Holdings, Inc. (RANI) had 9 insider filings in the last 90 days, with the most recent on 2026-06-05. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying RANI stock?: 0 insider purchases of RANI were filed in the last 90 days.
How many insiders are selling RANI stock?: 0 insider sales of RANI were filed in the last 90 days.
Where can I see RANI SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every RANI SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live RANI dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.